A One-year Trajectory of Depression Status Changes in Older Adults With MCI and SD: a Longitudinal Cohort Study
1 other identifier
observational
466
1 country
1
Brief Summary
The purpose of this study is to investigate the one-year trajectory of changes in depression status in older adults with mild cognitive impairment and subthreshold depression, and to explore relevant risk factors for predicting changes in depression status. This one-year prospective longitudinal follow-up study involved 400 (expected) subjects who met the diagnostic criteria for mild cognitive impairment combined with subthreshold depression in older adults, and their depressive status was assessed using the Geriatric Depression Scale (GDS). Follow up monitoring of depression status at 6 and 12 months. Obtain factors related to changes in depressive status (such as age, gender, education level, cognitive function, anxiety level, sleep status, social support, psychological resilience, social network, etc.). By studying the longitudinal trajectory of depression status in elderly patients with mild cognitive impairment and subthreshold depression, a multi state Markov model with time and state discreteness is constructed, namely: State 1 (normal); State 2 (subthreshold depression); State 3 (mild depression); State 4 (moderate depression); State 5 (severe depression). Deeply explore and analyze the impact of certain factors and indicators on the transition between states, and estimate the probability of transition between states.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2023
CompletedFirst Submitted
Initial submission to the registry
March 4, 2024
CompletedFirst Posted
Study publicly available on registry
March 13, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2024
CompletedNovember 27, 2024
November 1, 2024
1.2 years
March 4, 2024
November 25, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Depressive state
The Geriatric Depression Scale (GDS-15) is used to investigate the psychological feelings of patients in the past week. Result evaluation criteria: The total score range is 0-15 points, with higher scores indicating more severe depression. 1-5 points are subthreshold depression, 6-7 points are mild depression, 8-11 points are moderate depression, and 12-15 points are severe depression.
2023.6.1-2024.7.1
Secondary Outcomes (8)
General information of patients
2023.6.1-2024.7.1
Cognitive
2023.6.1-2024.7.1
Activity of Daily Living
2023.6.1-2024.7.1
Anxiety
2023.6.1-2024.7.1
Social Function
2023.6.1-2024.7.1
- +3 more secondary outcomes
Eligibility Criteria
Select elderly patients with mild cognitive impairment and subthreshold depression who meet the inclusion and exclusion criteria from multiple elderly care institutions, a tertiary hospital in Fuzhou, and communities in Fujian Province as the research subjects.
You may qualify if:
- Age: ≥ 60 years old
- Meets the diagnostic criteria for mild cognitive impairment and subthreshold depression
- Having basic comprehension and verbal expression skills
- Voluntarily participate in this study and sign an informed consent form.
You may not qualify if:
- Diagnosed as depression patients, including patients with organic mental disorders and patients with a history of depression related mental disorders
- Cognitive impairment caused by other diseases (such as neurological and psychiatric disorders, metabolic disorders, poisoning, infections, etc.)
- Severe heart, liver, and kidney diseases
- Serious chronic diseases and complications, such as congestive heart failure, hypertension, diabetes and other diseases with serious complications
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Fujian provincial hospital
Fuzhou, Fujian, 350000, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
DanTing Chen
Fujian Medical University
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
March 4, 2024
First Posted
March 13, 2024
Study Start
June 1, 2023
Primary Completion
August 1, 2024
Study Completion
August 1, 2024
Last Updated
November 27, 2024
Record last verified: 2024-11
Data Sharing
- IPD Sharing
- Will not share